Epigral Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Limited has submitted its financial results for the period ending December 31, 2025 to the NSE exchange. The filing is a standard regulatory compliance announcement under listing obligations. No specific financial figures, revenue numbers, or profit details are included in this headline filing — the detailed results would be available in the accompanying financial document. Investors should refer to the full results PDF for actual performance metrics and segment-wise breakdown.
No immediate price impact from this announcement alone; the actual market reaction will depend on the numbers disclosed in the detailed financial results, particularly revenue growth, profit margins, and any guidance for the remaining fiscal year.